Two-part Phase 1/2 study of OPK-88006, including an open-label SAD phase in healthy participants and a double-blind, randomized, placebo-controlled MAD phase in participants with presumed MASH, to evaluate safety, PK, and MASH related pharmacodynamic changes compared to placebo.
Age range
18 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
SAD - OPK-88006 maximum plasma concentration (Cmax)
Timeframe: 2 hours to 1 week
SAD - OPK-88006 Time to peak (Tmax)
Timeframe: 2 hours to 1 week
SAD - OPK-88006 Elimination half-life (T1/2)
Timeframe: 10 hours to 200 hours
SAD - Frequency of treatment emergent adverse events (TEAE)
Timeframe: Up to 2 weeks
MAD - Frequency of treatment emergent adverse events (TEAE)
Timeframe: Up to 20 weeks
MAD - Change in body weight
Timeframe: Up to 17 weeks
MAD - Change in fasting lipids
Timeframe: Up to 17 weeks
MAD - Change in liver enzymes, alanine aminotransferase (ALT) and aspartate aminotransferase (AST)
Timeframe: Up to 17 weeks
MAD - Change in liver stiffness with Vibration-controlled Transient Elastography (VCTE)
Timeframe: Up to 17 weeks
MAD - Change in fibrosis markers measured by Enhanced Liver Fibrosis (ELF) score
Timeframe: Up to 17 weeks
MAD - Change in hepatic fat measured by MRI-PDFF
Timeframe: Up to 17 weeks